-
Mashup Score: 0
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
Treatment with pelabresib plus Jakafi was linked with an improvement in patients with myelofibrosis, including spleen size, according to a presentation at #ASH24. #MPN #bloodcancer Read more: https://t.co/dc2wisPI7D